Channels
All News
In Focus
Special
AI
Bioregnum
Biotech Voices
Cell/Gene Tx
China
Coronavirus
Deals
Diagnostics
Discovery
FDA+
Financing
Health Tech
Law
Letters to the Editor
Manufacturing
Marketing
Nikkei Biotechnology
Opinion
Outsourcing
Peer Review
People
Pharma
R&D
Startups
Weekly
Webinars
Biopharma Jobs
More
Work at Endpoints
Letter to Editors
Editorial Standards
IPO Tracker
Webinars
Events
Sponsored Posts
Advertise
Privacy Policy
Endpoints Merch
About Us
Help
SIGN UP
LOG IN
FDA+ channel feed
Damn the critics, Biogen CEO Vounatsos orders full speed ahead on prepping a controversial aducanumab launch as FDA decision looms
5 years ago
Bioregnum
Law professors call for FDA to disclose all safety and efficacy data for drugs
5 years ago
Pharma
Why remote drug manufacturing evaluations won't really reduce FDA's backlog of inspections
5 years ago
Manufacturing
FDA offers scathing review of Emergent plant's sanitary conditions, employee training after halting production
5 years ago
House Democrats call on Emergent execs to testify on quality issues next month
5 years ago
Pharma
Manufacturing
Opinion: US and EU reviews of blood clots and J&J’s Covid vaccine show why a transparent process matters
5 years ago
Opinion
J&J to restart Covid vaccine shipments to Europe as EMA adds safety warning over rare blood clots
5 years ago
Coronavirus
Amgen's promising gastric cancer drug makes good on Five Prime potential with FDA's breakthrough nod
5 years ago
FDA slaps a hold on KalVista's PhII study of an HAE drug, raising a red flag on preclinical results
5 years ago
R&D
FDA slaps a hold on Moffitt’s next-gen CAR-T as regulators demand another delay on clinical work — shares crater
5 years ago
R&D
When is a drug really a device? Court knocks down FDA appeal in trying to sort that grey area
5 years ago
Pharma
FDA revokes EUA for Eli Lilly Covid-19 treatment
5 years ago
Coronavirus
PDUFA VII to expand FDA’s real-time oncology reviews to supplements for all therapeutic areas
5 years ago
Sponsors should flag decentralized aspects of cancer trials to prep for the post-Covid era, FDA says
5 years ago
Coronavirus
Exclusive interview: Peter Marks on why full Covid-19 vaccine approvals could be just months away
5 years ago
Coronavirus
Janet Woodcock on if the FDA is getting tougher on drug reviews: ‘I don’t think so’
5 years ago
Pharma
Former head of FDA’s medical and scientific affairs on Covid: ‘FDA has never been tested like this’
5 years ago
People
Fifth Circuit sides with FTC in major pay-for-delay settlement case
5 years ago
Pharma
Opinion: Biden needs to step up and nominate an FDA commissioner
5 years ago
Opinion
FDA dispenses with in-person requirement for abortion pill access during the pandemic
5 years ago
Pharma
J&J pauses vaccine rollout as feds probe rare cases of blood clots
5 years ago
Coronavirus
Patrizia Cavazzoni named permanent director of CDER, adding to questions around where Woodcock will end up
5 years ago
People
Gene therapies for neurodegenerative diseases: Pfizer, Novartis, Biogen and others seek more from FDA
5 years ago
Cell/Gene Tx
EMA investigating 4 'serious cases' of blood clots following J&J vaccinations
5 years ago
Coronavirus
First page
Previous page
111
112
113
114
115
116
117
Next page
Last page